Artificial intelligence detects cancer with 17% more accuracy than doctors in UCLA study
Fox News
|
Summary
A UCLA study revealed that artificial intelligence, specifically the Unfold AI software developed by Avenda Health, can detect prostate cancer with 84% accuracy, outperforming doctors who have a 67% detection rate. The AI software, which uses clinical data to create 3D cancer estimation maps, was found to have a significantly higher "negative margin rate," indicating a much lower chance of leaving residual cancer cells behind. This technological advancement, recently approved by the FDA, promises to improve the personalization and effectiveness of prostate cancer treatments, potentially reducing the need for invasive procedures and their associated side effects. However, experts caution that while AI can enhance diagnostic accuracy, it should complement, not replace, clinicians' judgment and patient data privacy must be maintained.
